In-house roundup: Poll: earning in-house trust essential; CRISPR licensees hold tight

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: Poll: earning in-house trust essential; CRISPR licensees hold tight

CRISPR 168

Managing IP rounds up the latest news and analysis from patent-focused businesses



CRISPR main

Poll: earning in-house trust is essential to winning business

Businesses describe the perfect pitch, the ideal partner-to-associate ratio and procurement practices in part two of a Patent Strategy survey on hiring external counsel. Read more... 

CRISPR licensees hold tight as patent skirmishes play out

With the patent wars continuing to rage at the IP offices between key patent owners, in-house counsel say they are waiting for the matter to sort itself out so they can progress with licensing deals. Read more... 




more from across site and SHARED ros bottom lb

More from across our site

Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Gift this article